Project Oncology® presents a wide array of oncology topics designed to educate and enlighten practitioners on late-breaking discoveries, novel treatment options, evolving methods of patient management, and more. This series provides cutting-edge updates on cancer biology, diagnosis, and multidisciplinary management, as well as evidence-based recommendations to achieve optimal patient outcomes.
Host: Jacob Sands, MD Guest: Derek Raghavan, MD, PhD, FACP, FRACP CT scans have the potential to dramatically improve lung cancer outcomes, but are un...
Host: Matt Birnholz, MD Guest: Jacob Sands, MD ReachMD hosts Drs. Matt Birnholz and Jacob Sands come together to discuss the rationales, limitations, ...
Guest: David R. Gandara, MD Dr. David R. Gandara walks us through some of the most recent clinical trial data on non-small cell lung cancer from the 2...
Guest: Rami Manochakian, MD Dr. Rami Manochakian, a thoracic medical oncologist at the Mayo Clinic, dives into three clinical trials on developments i...
Host: Jacob Sands, MD ReachMD host Dr. Jacob Sands joins us to share key updates that were presented on lung cancer at the American Society of Clinica...
Guest: Fred R. Hirsch, MD, PhD Dr. Fred R. Hirsch, Executive Director at the Center for Thoracic Oncology in the Tisch Cancer Institute at Mount Sinai...
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Lincoln Nadauld, MD, PhD Current cancer screening methods like mammograms, colonoscopies, and CT scans...
Host: Paul Paik, MD Guest: Joshua K. Sabari, MD For the 3% to 4% of patients with non-small cell lung cancer (NSCLC) who harbor a MET exon 14 skipping...
Host: Paul Paik, MD Guest: Joshua K. Sabari, MD For the 3% to 4% of patients with non-small cell lung cancer (NSCLC) who harbor a MET exon 14 skipping...
Host: Jacob Sands, MD Guest: Millie Das, MD What are some of the latest advancements in small cell lung cancer? Dr. Jacob Sands discusses small-cell l...